But it is documented with other biologic medications, and the mechanism applies to semaglutide as well
Immunologic Very common (10% or more): Positive for antidrug antibodies (up to 15.3%) Common (1% to 10%): Positive for antibodies against native glucagon-like peptide-1 (GLP-1) The proportion of patients testing positive for antidrug antibodies at any time postbaseline was up to 11.2% for the 2.4 mg dosage and up to 15.4% for the 7.2 mg dosage
$130 Billion 1 Projected Market Size of GLP-1 therapies in 2030 10-20% Body Weight Reduction 4 Treatment Breakthrough 42% of U.S
With ultra-high polyphenol oils exceeding 2,000 mg/kg, a daily serving of 5 ml can provide equivalent or greater polyphenol intake
Laboratory research demonstrates that BPC-157 treatment accelerates wound healing in diverse injury models including alkali burns, surgical incisions, and chronic wounds, with the peptide enhancing proliferation, migration, and angiogenesis in vitro through dose-dependent ERK1/2 phosphorylation leading to increased cellular proliferation, migration, and vascular tube formation